Search research articles
Contact Us
Filters
Showing results (81-90 of 149) with videos related to
Page
of 15
Sort By:
Blood Advances
|
April 9, 2026
Growth and puberty in African children with sickle cell anemia treated with hydroxyurea
Philippe Backeljauw, George Tomlinson, Luke R Smart, et al.
Bone Marrow Transplantation
|
February 1, 2019
A novel strategy for identifying early acute kidney injury in pediatric hematopoietic stem cell transplantation
Stefanie W Benoit, Bradley P Dixon, Stuart L Goldstein, et al.
The New England Journal of Medicine
|
May 27, 2026
Ten Years of Hydroxyurea for Ugandan Children with Sickle Cell Anemia
Russell E Ware, Robert O Opoka, Teresa Latham, et al.
American Journal of Hematology
|
February 9, 2024
Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial
Alexandra Power-Hays, George A Tomlinson, Leon Tshilolo, et al.
Pediatric Neurosurgery
|
August 16, 2019
Magnetic Resonance Fingerprinting to Characterize Childhood and Young Adult Brain Tumors
Peter de Blank, Chaitra Badve, Deborah Rukin Gold, et al.
Blood Vessels, Thrombosis & Hemostasis
|
August 6, 2025
Angiopoietin-2 is associated with sickle cell complications, including stroke risk, and decreases with hydroxyurea therapy
Thomas F Siegert, Robert O Opoka, Maria Nakafeero, et al.
Blood
|
May 31, 2014
Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults
Sonata Jodele, Stella M Davies, Adam Lane, et al.
Haematologica
|
February 19, 2026
Neutrophil extracellular traps, endothelial injury and use of abatacept for graft <i>versus</i> host disease prophylaxis
Azada Ibrahimova, Nathan Luebbering, Lauren Strecker, et al.
Transplantation and Cellular Therapy
|
May 1, 2022
Transplantation-Associated Thrombotic Microangiopathy Risk Stratification: Is There a Window of Opportunity to Improve Outcomes?
Sonata Jodele, Christopher E Dandoy, Anthony Sabulski, et al.
Oncotarget
|
June 7, 2018
Combined mTOR and MEK inhibition is an effective therapy in a novel mouse model for angiosarcoma
Michelle L Chadwick, Adam Lane, Dana Thomas, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 149) with videos related to
Sort By:
Page
of 15
Blood Advances
|
April 9, 2026
Growth and puberty in African children with sickle cell anemia treated with hydroxyurea
Philippe Backeljauw, George Tomlinson, Luke R Smart, et al.
Bone Marrow Transplantation
|
February 1, 2019
A novel strategy for identifying early acute kidney injury in pediatric hematopoietic stem cell transplantation
Stefanie W Benoit, Bradley P Dixon, Stuart L Goldstein, et al.
The New England Journal of Medicine
|
May 27, 2026
Ten Years of Hydroxyurea for Ugandan Children with Sickle Cell Anemia
Russell E Ware, Robert O Opoka, Teresa Latham, et al.
American Journal of Hematology
|
February 9, 2024
Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial
Alexandra Power-Hays, George A Tomlinson, Leon Tshilolo, et al.
Pediatric Neurosurgery
|
August 16, 2019
Magnetic Resonance Fingerprinting to Characterize Childhood and Young Adult Brain Tumors
Peter de Blank, Chaitra Badve, Deborah Rukin Gold, et al.
Blood Vessels, Thrombosis & Hemostasis
|
August 6, 2025
Angiopoietin-2 is associated with sickle cell complications, including stroke risk, and decreases with hydroxyurea therapy
Thomas F Siegert, Robert O Opoka, Maria Nakafeero, et al.
Blood
|
May 31, 2014
Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults
Sonata Jodele, Stella M Davies, Adam Lane, et al.
Haematologica
|
February 19, 2026
Neutrophil extracellular traps, endothelial injury and use of abatacept for graft <i>versus</i> host disease prophylaxis
Azada Ibrahimova, Nathan Luebbering, Lauren Strecker, et al.
Transplantation and Cellular Therapy
|
May 1, 2022
Transplantation-Associated Thrombotic Microangiopathy Risk Stratification: Is There a Window of Opportunity to Improve Outcomes?
Sonata Jodele, Christopher E Dandoy, Anthony Sabulski, et al.
Oncotarget
|
June 7, 2018
Combined mTOR and MEK inhibition is an effective therapy in a novel mouse model for angiosarcoma
Michelle L Chadwick, Adam Lane, Dana Thomas, et al.
Page
of 15